Reported 3 days ago
Vericel Corporation (NASDAQ:VCEL) is struggling as burn care revenue remains unpredictable, and growth from its leading product MACI is not meeting expectations. Following a challenging first quarter in 2025, with shares down 14.19% over the past year, Conestoga Capital Advisors expressed concerns about the company’s future growth potential despite achieving record quarterly revenue. Investors are increasingly cautious, leading to a shift towards safer assets in the market.
Source: YAHOO